Erratum
Erratum to “Guidelines for the medical treatment of idiopathic pulmonary fibrosis” <[Arch. Bronconeumol. 53 (2017) 263–269]>
Fe de errores de «Normativa sobre el tratamiento farmacológico de la fibrosis pulmonar idiopática» <[Arch Bronconeumol. 53 (2017) 263-9]>
Antoni Xaubeta,b,
, María Molina-Molinab,c, Orlando Acostad, Elena Bolloe, Diego Castillof, Estrella Fernández-Fabrellasg, José Antonio Rodríguez-Portalb,h, Claudia Valenzuelai, Julio Ancocheai
Corresponding author
a Servicio de Neumología, Hospital Clínic, Barcelona, Spain
b Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Spain
c Unidad Funcional del Intersticio Pulmonar (UFIP), Servicio de Neumología, Hospital Universitario de Bellvitge-Instituto de Investigación Biomédica de Bellvitge (IDIBELL), L’Hospitalet de Llobregat, Barcelona, Spain
d Servicio de Neumología, Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain
e Servicio de Neumología, Complejo Asistencial Universitario de León, León, Spain
f Servicio de Neumología, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
g Servicio de Neumología, Consorcio Hospital General Universitario de Valencia, Valencia, Spain
h Servicio de Neumología, Hospital Universitario Virgen del Rocío, Sevilla, Spain
i Servicio de Neumología, Hospital Universitario de La Princesa, Universidad Autónoma de Madrid, Madrid, Spain
Ver másRead
4409
Timeswas read the article
1786
Total PDF
2623
Total HTML
Share statistics
array:23 [ "pii" => "S1579212917302008" "issn" => "15792129" "doi" => "10.1016/j.arbr.2017.06.002" "estado" => "S300" "fechaPublicacion" => "2017-11-01" "aid" => "1664" "copyrightAnyo" => "2017" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "err" "cita" => "Arch Bronconeumol. 2017;53:657-8" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 1325 "formatos" => array:3 [ "EPUB" => 144 "HTML" => 759 "PDF" => 422 ] ] "Traduccion" => array:1 [ "es" => array:18 [ "pii" => "S0300289617302193" "issn" => "03002896" "doi" => "10.1016/j.arbres.2017.06.010" "estado" => "S300" "fechaPublicacion" => "2017-11-01" "aid" => "1664" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "err" "cita" => "Arch Bronconeumol. 2017;53:657-8" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 2227 "formatos" => array:3 [ "EPUB" => 135 "HTML" => 1466 "PDF" => 626 ] ] "es" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Fe de errores</span>" "titulo" => "Fe de errores de «Normativa sobre el tratamiento farmacológico de la fibrosis pulmonar idiopática» <[Arch Bronconeumol. 53 (2017) 263-9] >" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "657" "paginaFinal" => "658" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Erratum to “Guidelines for the medical treatment of idiopathic pulmonary fibrosis” <[Arch Bronconeumol. 53 (2017) 263–9] >" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figura 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1465 "Ancho" => 2500 "Tamanyo" => 234504 ] ] "descripcion" => array:1 [ "es" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Algoritmo del tratamiento farmacológico de la fibrosis pulmonar idiopática.</p> <p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">CVF: capacidad vital forzada; Dlco: capacidad de transferencia del monóxido de carbono.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Antoni Xaubet, María Molina-Molina, Orlando Acosta, Elena Bollo, Diego Castillo, Estrella Fernández-Fabrellas, José Antonio Rodríguez-Portal, Claudia Valenzuela, Julio Ancochea" "autores" => array:9 [ 0 => array:2 [ "nombre" => "Antoni" "apellidos" => "Xaubet" ] 1 => array:2 [ "nombre" => "María" "apellidos" => "Molina-Molina" ] 2 => array:2 [ "nombre" => "Orlando" "apellidos" => "Acosta" ] 3 => array:2 [ "nombre" => "Elena" "apellidos" => "Bollo" ] 4 => array:2 [ "nombre" => "Diego" "apellidos" => "Castillo" ] 5 => array:2 [ "nombre" => "Estrella" "apellidos" => "Fernández-Fabrellas" ] 6 => array:2 [ "nombre" => "José Antonio" "apellidos" => "Rodríguez-Portal" ] 7 => array:2 [ "nombre" => "Claudia" "apellidos" => "Valenzuela" ] 8 => array:2 [ "nombre" => "Julio" "apellidos" => "Ancochea" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S1579212917302008" "doi" => "10.1016/j.arbr.2017.06.002" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1579212917302008?idApp=UINPBA00003Z" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0300289617302193?idApp=UINPBA00003Z" "url" => "/03002896/0000005300000011/v1_201710310034/S0300289617302193/v1_201710310034/es/main.assets" ] ] "itemAnterior" => array:19 [ "pii" => "S1579212917303142" "issn" => "15792129" "doi" => "10.1016/j.arbr.2017.09.009" "estado" => "S300" "fechaPublicacion" => "2017-11-01" "aid" => "1708" "copyright" => "SEPAR" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Arch Bronconeumol. 2017;53:655-6" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 2259 "formatos" => array:3 [ "EPUB" => 142 "HTML" => 1518 "PDF" => 599 ] ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "Core Needle Biopsy Versus Fine Needle Aspiration Biopsy in Diagnosing Lung Cancer" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "655" "paginaFinal" => "656" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Biopsia con aguja gruesa versus punción aspiración con aguja fina en el diagnóstico del cáncer de pulmón" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Felipe Villar Álvarez, Ignacio Muguruza Trueba, Javier Flandes Aldeyturriaga" "autores" => array:3 [ 0 => array:2 [ "nombre" => "Felipe" "apellidos" => "Villar Álvarez" ] 1 => array:2 [ "nombre" => "Ignacio" "apellidos" => "Muguruza Trueba" ] 2 => array:2 [ "nombre" => "Javier" "apellidos" => "Flandes Aldeyturriaga" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0300289617302909" "doi" => "10.1016/j.arbres.2017.09.001" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0300289617302909?idApp=UINPBA00003Z" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1579212917303142?idApp=UINPBA00003Z" "url" => "/15792129/0000005300000011/v2_201711201359/S1579212917303142/v2_201711201359/en/main.assets" ] "asociados" => array:1 [ 0 => array:19 [ "pii" => "S1579212917300782" "issn" => "15792129" "doi" => "10.1016/j.arbr.2017.03.001" "estado" => "S300" "fechaPublicacion" => "2017-05-01" "aid" => "1544" "copyright" => "SEPAR" "documento" => "article" "crossmark" => 1 "subdocumento" => "fla" "cita" => "Arch Bronconeumol. 2017;53:263-9" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 3742 "formatos" => array:3 [ "EPUB" => 190 "HTML" => 2419 "PDF" => 1133 ] ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">SEPAR's voice</span>" "titulo" => "Guidelines for the Medical Treatment of Idiopathic Pulmonary Fibrosis" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "263" "paginaFinal" => "269" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Normativa sobre el tratamiento farmacológico de la fibrosis pulmonar idiopática" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1759 "Ancho" => 3007 "Tamanyo" => 292094 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">IPF pharmacological treatment algorithm. FVC: forced vital capacity; DL<span class="elsevierStyleInf">CO</span>: carbon monoxide diffusing capacity.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Antoni Xaubet, María Molina-Molina, Orlando Acosta, Elena Bollo, Diego Castillo, Estrella Fernández-Fabrellas, José Antonio Rodríguez-Portal, Claudia Valenzuela, Julio Ancochea" "autores" => array:9 [ 0 => array:2 [ "nombre" => "Antoni" "apellidos" => "Xaubet" ] 1 => array:2 [ "nombre" => "María" "apellidos" => "Molina-Molina" ] 2 => array:2 [ "nombre" => "Orlando" "apellidos" => "Acosta" ] 3 => array:2 [ "nombre" => "Elena" "apellidos" => "Bollo" ] 4 => array:2 [ "nombre" => "Diego" "apellidos" => "Castillo" ] 5 => array:2 [ "nombre" => "Estrella" "apellidos" => "Fernández-Fabrellas" ] 6 => array:2 [ "nombre" => "José Antonio" "apellidos" => "Rodríguez-Portal" ] 7 => array:2 [ "nombre" => "Claudia" "apellidos" => "Valenzuela" ] 8 => array:2 [ "nombre" => "Julio" "apellidos" => "Ancochea" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0300289617300212" "doi" => "10.1016/j.arbres.2016.12.011" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0300289617300212?idApp=UINPBA00003Z" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1579212917300782?idApp=UINPBA00003Z" "url" => "/15792129/0000005300000005/v1_201704280925/S1579212917300782/v1_201704280925/en/main.assets" ] ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Erratum</span>" "titulo" => "Erratum to “Guidelines for the medical treatment of idiopathic pulmonary fibrosis” <[Arch. Bronconeumol. 53 (2017) 263–269]>" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "657" "paginaFinal" => "658" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Antoni Xaubet, María Molina-Molina, Orlando Acosta, Elena Bollo, Diego Castillo, Estrella Fernández-Fabrellas, José Antonio Rodríguez-Portal, Claudia Valenzuela, Julio Ancochea" "autores" => array:9 [ 0 => array:4 [ "nombre" => "Antoni" "apellidos" => "Xaubet" "email" => array:1 [ 0 => "axaubetmir@gmail.com" ] "referencia" => array:3 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] 2 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 1 => array:3 [ "nombre" => "María" "apellidos" => "Molina-Molina" "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "aff0015" ] ] ] 2 => array:3 [ "nombre" => "Orlando" "apellidos" => "Acosta" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">d</span>" "identificador" => "aff0020" ] ] ] 3 => array:3 [ "nombre" => "Elena" "apellidos" => "Bollo" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">e</span>" "identificador" => "aff0025" ] ] ] 4 => array:3 [ "nombre" => "Diego" "apellidos" => "Castillo" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">f</span>" "identificador" => "aff0030" ] ] ] 5 => array:3 [ "nombre" => "Estrella" "apellidos" => "Fernández-Fabrellas" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">g</span>" "identificador" => "aff0035" ] ] ] 6 => array:3 [ "nombre" => "José Antonio" "apellidos" => "Rodríguez-Portal" "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">h</span>" "identificador" => "aff0040" ] ] ] 7 => array:3 [ "nombre" => "Claudia" "apellidos" => "Valenzuela" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">i</span>" "identificador" => "aff0045" ] ] ] 8 => array:3 [ "nombre" => "Julio" "apellidos" => "Ancochea" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">i</span>" "identificador" => "aff0045" ] ] ] ] "afiliaciones" => array:9 [ 0 => array:3 [ "entidad" => "Servicio de Neumología, Hospital Clínic, Barcelona, Spain" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Spain" "etiqueta" => "b" "identificador" => "aff0010" ] 2 => array:3 [ "entidad" => "Unidad Funcional del Intersticio Pulmonar (UFIP), Servicio de Neumología, Hospital Universitario de Bellvitge-Instituto de Investigación Biomédica de Bellvitge (IDIBELL), L’Hospitalet de Llobregat, Barcelona, Spain" "etiqueta" => "c" "identificador" => "aff0015" ] 3 => array:3 [ "entidad" => "Servicio de Neumología, Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain" "etiqueta" => "d" "identificador" => "aff0020" ] 4 => array:3 [ "entidad" => "Servicio de Neumología, Complejo Asistencial Universitario de León, León, Spain" "etiqueta" => "e" "identificador" => "aff0025" ] 5 => array:3 [ "entidad" => "Servicio de Neumología, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain" "etiqueta" => "f" "identificador" => "aff0030" ] 6 => array:3 [ "entidad" => "Servicio de Neumología, Consorcio Hospital General Universitario de Valencia, Valencia, Spain" "etiqueta" => "g" "identificador" => "aff0035" ] 7 => array:3 [ "entidad" => "Servicio de Neumología, Hospital Universitario Virgen del Rocío, Sevilla, Spain" "etiqueta" => "h" "identificador" => "aff0040" ] 8 => array:3 [ "entidad" => "Servicio de Neumología, Hospital Universitario de La Princesa, Universidad Autónoma de Madrid, Madrid, Spain" "etiqueta" => "i" "identificador" => "aff0045" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Fe de errores de «Normativa sobre el tratamiento farmacológico de la fibrosis pulmonar idiopática» <[Arch Bronconeumol. 53 (2017) 263-9]>" ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1466 "Ancho" => 2500 "Tamanyo" => 231768 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">IPF pharmacological treatment algorithm. FVC: forced vital capacity; DL<span class="elsevierStyleInf">CO</span>: carbon monoxide diffusing capacity.</p>" ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">Several errors have been detected in <a class="elsevierStyleCrossRefs" href="#tbl0005">Tables 1 and 5</a>, in <a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>, and in the text of the article “Guidelines for the medical treatment of idiopathic pulmonary fibrosis” [Arch Bronconeumol. 2017;53:263–9]”.</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><elsevierMultimedia ident="tbl0010"></elsevierMultimedia><p id="par0040" class="elsevierStylePara elsevierViewall">The following tables are the correct versions:</p><p id="par0010" class="elsevierStylePara elsevierViewall">The following text is the correct version:<ul class="elsevierStyleList" id="lis0005"><li class="elsevierStyleListItem" id="lsti0005"><span class="elsevierStyleLabel">-</span><p id="par0015" class="elsevierStylePara elsevierViewall">Page 3, section “Nintedanib (Ofev<span class="elsevierStyleSup">®</span>)”, line 47. Where it says: “In the INPULSIS studies, patients with cardiovascular risk were excluded, so safety in this population could not be determined (Table 3). Table 4 shows nintedanib drug interactions.”, it should say: “Table 4 shows nintedanib drug interactions.”</p></li><li class="elsevierStyleListItem" id="lsti0010"><span class="elsevierStyleLabel">-</span><p id="par0020" class="elsevierStylePara elsevierViewall">Page 5, section “Antifibrotics in Clinical Trials”, line 23. Where it says “Other combinations of pirfenidone or nintedanib with other new antifibrotics, initiated before either drug received marketing approval, are also ongoing (<a href="http://www.clinicaltrials.gov/">www.clinicaltrials.gov</a>), including pirfenidone±lebrikizumab (RIFF study), pirfenidone or nintedanib±PRM-151 (PROME-DIOR study), pirfenidone±vismodegib (GB29764 study), pirfenidone±sildenafil.”, it should say: “Other combinations of pirfenidone or nintedanib with other new antifibrotics, initiated before either drug received marketing approval, are also ongoing (<a href="http://www.clinicaltrials.gov/">www.clinicaltrials.gov</a>), including pirfenidone±lebrikizumab (RIFF study), pirfenidone or nintedanib±PRM-151 (PROME-DIOR study), pirfenidone±vismodegib (GB29764 study), pirfenidone±sildenafil, nintedanib+/−sildenafil (INSTAGE study) and other clinical trials in progress such as NCTO2606877 (nintedanib+pirfenidone and the INMARK study.”</p></li><li class="elsevierStyleListItem" id="lsti0015"><span class="elsevierStyleLabel">-</span><p id="par0025" class="elsevierStylePara elsevierViewall">Page 5, the section title “Pulmonary Emphysema” should be replaced by: “Combined pulmonary fibrosis and emphysema (CPFE)”.</p></li><li class="elsevierStyleListItem" id="lsti0020"><span class="elsevierStyleLabel">-</span><p id="par0030" class="elsevierStylePara elsevierViewall">Page 5, section “Pulmonary Emphysema”, line 1. Where it says: “No effective treatment is currently available for combined pulmonary fibrosis and emphysema (CPFE) syndrome,<span class="elsevierStyleSup">35,36</span> so it seems logical to base therapeutic decisions on the separate recommendations for emphysema and IPF.”, it should say: “No effective treatment is currently available for pulmonary syndrome,<span class="elsevierStyleSup">35,36</span> so it seems logical to base therapeutic decisions on the separate recommendations for emphysema and IPF.”</p></li></ul></p><p id="par0035" class="elsevierStylePara elsevierViewall">The following <a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a> is the correct version:</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia></span>" "pdfFichero" => "main.pdf" "tienePdf" => true "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as: Xaubet A, Molina-Molina M, Acosta O, Bollo E, Castillo D, Fernández-Fabrellas E, et al. Fe de errores de «Normativa sobre el tratamiento farmacológico de la fibrosis pulmonar idiopática» [Arch Bronconeumol. 53 (2017) 263-9]. Arch Bronconeumol. 2017;53:657–658.</p>" ] ] "multimedia" => array:3 [ 0 => array:7 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1466 "Ancho" => 2500 "Tamanyo" => 231768 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">IPF pharmacological treatment algorithm. FVC: forced vital capacity; DL<span class="elsevierStyleInf">CO</span>: carbon monoxide diffusing capacity.</p>" ] ] 1 => array:8 [ "identificador" => "tbl0005" "etiqueta" => "Table 1" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at1" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:2 [ "leyenda" => "<p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">DLCO: carbon monoxide diffusing capacity; FVC: forced vital capacity; HRCT: high-resolution computed tomography; UIP: usual interstitial pneumonia.</p>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="" valign="top" scope="col" style="border-bottom: 2px solid black"> \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">CAPACITY-1 and -2 (<span class="elsevierStyleItalic">n</span>=779) \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">ASCEND (<span class="elsevierStyleItalic">n</span>=555) \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Age (years) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">40–80 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">40–80 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">FVC (inclusion criterion) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">≥50%–90% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">50–90% \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">DLCO (inclusion criterion) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">≥35%–90% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">≥30%–90% \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Phase \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">III \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">III \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Study duration (weeks) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">72 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">52 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">UIP on HRCT \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">92% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">95.7% \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Initial FVC (mean) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">74.1% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">67.8% \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Initial DLCO (mean) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">47% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">43.7% \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab1592650.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">CAPACITY-1 and -2 and ASCEND Clinical Trials: Methodology and Clinical Features of IPF Patients Included.</p>" ] ] 2 => array:8 [ "identificador" => "tbl0010" "etiqueta" => "Table 5" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at2" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:2 [ "leyenda" => "<p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">DLCO: carbon monoxide diffusing capacity; FVC: forced vital capacity; HRCT: high-resolution computed tomography; UIP: usual interstitial pneumonia.</p>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="" valign="top" scope="col" style="border-bottom: 2px solid black"> \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">TOMORROW (<span class="elsevierStyleItalic">n</span>=422, 85 at doses of 150<span class="elsevierStyleHsp" style=""></span>mg/12<span class="elsevierStyleHsp" style=""></span>h) \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">INPULSIS-1 and -2 (<span class="elsevierStyleItalic">n</span>=1066) \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Age (years) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">>40 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">>40 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">FVC (inclusion criterion) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">≥50% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">≥50% \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">DLCO (inclusion criterion) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">30%–79% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">30%–79% \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Phase \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">II \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">III \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Study duration (weeks) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">52 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">52 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">UIP on HRCT \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">38.8% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">76% \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Initial FVC (mean) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">78.1% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">79.5% \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Initial DLCO (mean) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">– \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">47% \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab1592651.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">TOMORROW and INPULSIS Clinical Trials: Methodology and Clinical Features of IPF Patients Included.</p>" ] ] ] ] "idiomaDefecto" => "en" "url" => "/15792129/0000005300000011/v2_201711201359/S1579212917302008/v2_201711201359/en/main.assets" "Apartado" => array:4 [ "identificador" => "9332" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Erratum" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/15792129/0000005300000011/v2_201711201359/S1579212917302008/v2_201711201359/en/main.pdf?idApp=UINPBA00003Z&text.app=https://archbronconeumol.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1579212917302008?idApp=UINPBA00003Z" ]
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 November | 6 | 0 | 6 |
| 2024 October | 54 | 18 | 72 |
| 2024 September | 37 | 11 | 48 |
| 2024 August | 70 | 36 | 106 |
| 2024 July | 41 | 30 | 71 |
| 2024 June | 60 | 34 | 94 |
| 2024 May | 78 | 30 | 108 |
| 2024 April | 50 | 27 | 77 |
| 2024 March | 45 | 19 | 64 |
| 2024 February | 33 | 17 | 50 |
| 2023 March | 7 | 6 | 13 |
| 2023 February | 52 | 21 | 73 |
| 2023 January | 29 | 23 | 52 |
| 2022 December | 55 | 25 | 80 |
| 2022 November | 50 | 29 | 79 |
| 2022 October | 65 | 37 | 102 |
| 2022 September | 35 | 24 | 59 |
| 2022 August | 41 | 59 | 100 |
| 2022 July | 34 | 57 | 91 |
| 2022 June | 31 | 33 | 64 |
| 2022 May | 40 | 32 | 72 |
| 2022 April | 42 | 34 | 76 |
| 2022 March | 32 | 34 | 66 |
| 2022 February | 40 | 26 | 66 |
| 2022 January | 59 | 33 | 92 |
| 2021 December | 34 | 48 | 82 |
| 2021 November | 33 | 36 | 69 |
| 2021 October | 47 | 52 | 99 |
| 2021 September | 39 | 47 | 86 |
| 2021 August | 29 | 38 | 67 |
| 2021 July | 23 | 23 | 46 |
| 2021 June | 35 | 43 | 78 |
| 2021 May | 44 | 49 | 93 |
| 2021 April | 117 | 112 | 229 |
| 2021 March | 61 | 29 | 90 |
| 2021 February | 35 | 29 | 64 |
| 2021 January | 26 | 9 | 35 |
| 2020 December | 29 | 16 | 45 |
| 2020 November | 36 | 19 | 55 |
| 2020 October | 29 | 15 | 44 |
| 2020 September | 16 | 10 | 26 |
| 2020 August | 25 | 14 | 39 |
| 2020 July | 20 | 22 | 42 |
| 2020 June | 19 | 7 | 26 |
| 2020 May | 24 | 13 | 37 |
| 2020 April | 27 | 18 | 45 |
| 2020 March | 20 | 13 | 33 |
| 2020 February | 22 | 19 | 41 |
| 2020 January | 24 | 18 | 42 |
| 2019 December | 22 | 19 | 41 |
| 2019 November | 18 | 22 | 40 |
| 2019 October | 27 | 12 | 39 |
| 2019 September | 27 | 12 | 39 |
| 2019 August | 22 | 12 | 34 |
| 2019 July | 21 | 24 | 45 |
| 2019 June | 19 | 9 | 28 |
| 2019 May | 33 | 28 | 61 |
| 2019 April | 37 | 32 | 69 |
| 2019 March | 56 | 26 | 82 |
| 2019 February | 37 | 16 | 53 |
| 2019 January | 34 | 23 | 57 |
| 2018 December | 45 | 20 | 65 |
| 2018 November | 62 | 35 | 97 |
| 2018 October | 69 | 20 | 89 |
| 2018 September | 36 | 14 | 50 |
| 2018 May | 25 | 3 | 28 |
| 2018 April | 31 | 13 | 44 |
| 2018 March | 64 | 20 | 84 |
| 2018 February | 37 | 29 | 66 |
| 2018 January | 1 | 3 | 4 |
Show all
